TY - JOUR
T1 - Utility of fiber-optic bronchoscopy in pulmonary infections among abdominal solid-organ transplant patients
T2 - A comprehensive review
AU - Sakpal, Sujit Vijay
AU - Donahue, Steven
AU - Crespo, Hector Saucedo
AU - Auvenshine, Christopher
AU - Agarwal, Suresh Kumar
AU - Nazir, Jawad
AU - Santella, Robert N.
AU - Steers, Jeffery
N1 - Publisher Copyright:
© 2018 Elsevier Ltd
PY - 2019/1
Y1 - 2019/1
N2 - Pulmonary infections are frequent complications in abdominal solid-organ transplantation (aSOT) which may threaten patient and allograft survival. Accurate diagnosis and treatment of pulmonary infections in this population can be challenging. Immunosuppressive therapy not only increases the risk of acquiring opportunistic and non-opportunistic infections, but it also impairs the inflammatory responses associated with microbial invasion which in an otherwise normal host produce clinical and radiologic responses that allow for early identification of the offending pathogen. Serologic testing is not a reliable diagnostic modality. Direct microbiological sampling is often necessary to make a definitive diagnosis early in the clinical course to optimize timely, targeted therapy while reducing the risk of developing antimicrobial resistance, and minimize adverse effects of therapy, if any. Fiber-optic bronchoscopy (FOB) with bronchoalveolar lavage (BAL) or transbronchial lung biopsy (TBB) offers such diagnostic advantage and possesses a potential therapeutic value too. This comprehensive review discusses the potential benefits of FOB alongside its risks and complications, indications and contraindications, and techniques. Additionally, the essay highlights FOB's utility and yield specifically with regard to type and timing of infections in aSOT patients.
AB - Pulmonary infections are frequent complications in abdominal solid-organ transplantation (aSOT) which may threaten patient and allograft survival. Accurate diagnosis and treatment of pulmonary infections in this population can be challenging. Immunosuppressive therapy not only increases the risk of acquiring opportunistic and non-opportunistic infections, but it also impairs the inflammatory responses associated with microbial invasion which in an otherwise normal host produce clinical and radiologic responses that allow for early identification of the offending pathogen. Serologic testing is not a reliable diagnostic modality. Direct microbiological sampling is often necessary to make a definitive diagnosis early in the clinical course to optimize timely, targeted therapy while reducing the risk of developing antimicrobial resistance, and minimize adverse effects of therapy, if any. Fiber-optic bronchoscopy (FOB) with bronchoalveolar lavage (BAL) or transbronchial lung biopsy (TBB) offers such diagnostic advantage and possesses a potential therapeutic value too. This comprehensive review discusses the potential benefits of FOB alongside its risks and complications, indications and contraindications, and techniques. Additionally, the essay highlights FOB's utility and yield specifically with regard to type and timing of infections in aSOT patients.
KW - Abdominal solid-organ transplantation
KW - Fiber-optic bronchoscopy
KW - Pulmonary infections
UR - http://www.scopus.com/inward/record.url?scp=85058646007&partnerID=8YFLogxK
U2 - 10.1016/j.rmed.2018.12.002
DO - 10.1016/j.rmed.2018.12.002
M3 - Review article
C2 - 30665523
AN - SCOPUS:85058646007
SN - 0954-6111
VL - 146
SP - 81
EP - 86
JO - Respiratory Medicine
JF - Respiratory Medicine
ER -